Figure 2.
Manufacturing of autologous PBMC-derived antigen-presenting feeder cells
(A) Expression of truncated HER2, CD80, and 4-1BBL on the cell surface of antigen-presenting feeder cells 24 h post-electroporation. (B) Percentage of truncated HER2, CD80, and 4-1BBL-positive cells over time for 5 days after transduction.
